SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $95.8 million in its third quarter.

The Salt Lake City-based company said it had a loss of 34 cents per share.

The biotechnology company posted revenue of $26.1 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $34.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX